Ishani Malhotra, Chief Executive Officer, and founder of Carcinotech, has over ten years of experience in oncology and stem cell research with degrees from the University of Edinburgh and a Certificate of Achievement from Harvard Medical School. She has experience working in oncology and stem cell research at Censo Biotechnologies, HCG Oncology hospitals, The Institute of Cytology and Preventative Oncology and Stempeutics, prior to launching Carcinotech. She was listed as a Director of the Year Regional finalist at the Institute of Directors Scotland 2021 awards, has won several awards at national and international platforms. She was most recently awarded Women Entrepreneur of the Year by Cancer Research Horizons at the 2024 Innovation and Entrepreneruship Awards as well as being last year's regional winner and UK finalist for the EY Entrepreneur of the Year Award 2023. She has established significant international partnerships to advance Carcinotech’s vision of providing personalised drug testing platforms to help those suffering from cancer. She worked with organisations across industry and academia including Cellink and Cancer Research UK to advance the validation of the company's technology.